Henry Schein | HSIC - Bruttoergebnis Vom Umsatz

Aktienkurs
75.34
Täglich Wechseln
-0.28 -0.37%
Monatlich
-1.52%
Jährlich
16.88%
Q2 Prognose
71.71




Bruttoergebnis Vom Umsatz Veränderung Datum
Agilent USD 946M 44M 2025-12
Align Technology USD 683.59M 44.39M 2025-12
Bruker USD 449.2M 69.8M 2025-12
Cardinal Health USD 2.4B 78M 2025-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cigna USD 56.45B 50.29B 2025-09
Concord Medical Services Hldg CNY -37.42M 26.25M 2023-06
Cooper Companies USD 695.2M 44.4M 2025-12
CVS Health USD 13.57B 239M 2025-12
Danaher USD 3.97B 443M 2025-12
Dentsply International USD 443M 2M 2025-12
Encompass Health USD 1.41B 786M 2025-09
Henry Schein USD 1.06B 37M 2025-12
Idexx Laboratories USD 658.11M 25.24M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Laboratory Of America USD 993.2M 31.9M 2025-12
McKesson USD 3.68B 143M 2025-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Owens Minor USD 272.05M 20.92M 2025-12
Quest Diagnostics USD 873M 37M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Stryker USD 4.49B 633M 2025-12
Tenet Healthcare USD 2.22B 22M 2025-09
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Universal Health Services USD 2.01B 158.68M 2025-09
Veradigm USD 83.44M 3.95M 2022-09
Waters USD 557.42M 97.44M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12
Zoetis USD 1.64B 73M 2025-12